Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Hovione, Upperton, Piramal Pharma, Syntegon, Evonik, and Fareva opened or announced plans to build new facilities.
By: Patrick Lavery
Editor’s Take: Companies put down roots on both sides of the Atlantic, expanding their capabilities in a number of areas.
This week on “The Friday Brief” … Hovione opened a new facility in East Windsor, NJ, doubling its U.S. spray-drying capacity.
In the UK, Upperton gained approval for a sterile manufacturing site, while Piramal Pharma is planning a solar power plant.
As for continental Europe, Syntegon opened its new oral solid dosage customer center in Germany. Evonik broke ground on a new project in Slovakia that will expand its biotechnology operations. And Fareva is expanding its pharma CDMO network by integrating a production site in Turkey.
The week was not without some M&A activity. The specialist CRO Single Cell Discoveries wrapped up its acquisition of TATAA Biocenter. And Lilly completed its acquisition of AtaiBeckley, adding an investigational program for treatment-resistant depression.
Lilly also entered its TuneLab AI/ML drug discovery platform into a partnership with Twist Bioscience. Another of our top 20 companies, Gilead, launched a collaboration of its own. This one is with the Pan American Health Organization, increasing twice-yearly HIV prevention access in Latin America and the Caribbean.
Elsewhere, Sanofi, UCB, and Opella have joined AstraZeneca as founding members of the Clean Heat Program. This initiative, spearheaded by supply chain intelligence network Secaro and global sustainability consultancy ERM, aims to reduce industrial emissions.
And finally, Thermo Fisher has introduced Invitrogen SuperScript V Reverse Transcriptase. This next-generation engineered enzyme is designed to make converting RNA to complementary DNA faster, easier, and more flexible.
That’s really just scratching the surface of what we have for you at contractpharma.com this week. Worth noting—next week is our 25th annual Contract Pharma Contracting & Outsourcing Conference. We’ll have all hands on deck from the Contract Pharma team, and we hope to see you there.
In fact, next week’s Friday Brief will be coming to you direct from the show in New Brunswick, NJ. Until then, sign up for our newsletters to get the latest (plus developments from the conference) right in your inbox.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !